Image-guided Navigation During Robotic Sentinel Node Removal (N21LND)
Prostate Cancer
About this trial
This is an interventional other trial for Prostate Cancer
Eligibility Criteria
Inclusion Criteria: Scheduled for abdominal robotic sentinel node resection ≥ 18 years old Provided written 'informed consent' Sentinel nodes should be fixed relative to retroperitoneal structures or major vessels. Exclusion Criteria: Metal hip implants / implants in the pelvic area Pacemaker, defibrillator
Sites / Locations
- Netherlands Cancer InstituteRecruiting
Arms of the Study
Arm 1
Experimental
Patients scheduled for sentinel node procedure
This is a single-center observational feasibility study to evaluate the overall performance of the surgical navigation system during robotic surgery, without impact on the surgical procedure itself. The duration of this study will be approximately 2.5 years. Patients scheduled for a sentinel node procedure at the NKI are eligible for inclusion. Patients are informed about the study before the planned surgery and, after being provided with the necessary information regarding participation in the study, will be asked for informed consent. No additional risk is expected using the NDI navigation setup. Patients will receive some additional radiation due to the CT scan during surgery; a perioperative CBCT scan (~ 4 mSv) is acquired. This extra dose is low, considering other standard imaging in these patients like, pre-operative imaging with SPECT/CT scans. After surgery, no further participation or cooperation of the patient is required.